簡介

本頁面提供了有關 Alan M Garber 已知的內部交易歷史的全面分析。內部人士包括公司的高管、董事或重要投資者。一般而言,基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是,他們必須透過Form 4向美國證券交易委員會(SEC)報告所有交易。盡管存在這些限制,學術研究表明,內部人士 - 整體而言 - 在自己公司中的投資表現往往優於市場。

平均交易盈利能力

「平均交易盈利能力」衡量了內部人士在過去三年中所有非計劃性的公開市場購買交易的平均回報率。計算過程包括檢查每筆交易,排除了作為10b5-1交易計劃的一部分的交易。然後,對每筆交易在3、6和12個月的表現進行平均,以生成該筆交易最終的表現指標。最終,將所有交易的表現指標進行平均,計算出內部人士的總體平均表現指標。列表僅包含在過去兩年中進行過至少三筆交易的內部人士。

如果內部人士的交易盈利能力顯示為"N/A",則可能是因為該內部人士在過去三年內沒有進行任何公開市場購買交易,或者他們進行的交易距離現在太近,無法計算出可靠的表現指標。

更新頻率:每日

查看收益最高的的內幕交易者列表。

報告內部持倉的公司

SEC文件顯示Alan M Garber已報告在以下公司擁有持倉或進行了交易:

證券 職位 最新報告的持倉
US:VRTX / Vertex Pharmaceuticals Incorporated Director 7,344
US:EXEL / Exelixis, Inc. Director 35,703
如何解讀這些圖表

以下圖表顯示了在Alan M Garber進行的每筆公開市場非計劃交易後證券的股價表現。非計劃交易是指沒有作為10b5-1交易計劃的一部分而進行的交易。股價表現以累積百分比變化的方式繪製。例如,如果一筆內部人士交易是在2019年1月1日進行的,該圖表將顯示該證券的每日百分比變化直至當前日期。如果在此期間股價從10美元漲至15美元,則股價的累積百分比變化將為50%。從10美元漲至20美元的價格變化將為100%,而從10美元跌至5美元的價格變化將為-50%。

最終,我們將評估內部人士的交易與股價的超額回報(正向或負向)之間的相關性,以判斷內部人士是否在交易中利用內部信息獲利。如果內部人士有這樣的行為,我們預期看到(a)購買後的正回報,或者(b)賣出後的負回報。對於情況(a),購買圖表將顯示一系列向上傾斜的曲線,表示每次購買後都有正回報。對於情況(b),賣出圖表將顯示一系列向下傾斜的曲線,表示每次賣出後都有負回報。

然而,僅憑這一點還不足以得出結論。例如,如果公司的股價在多年內呈現非周期性上升,我們會預期所有購買後的圖表都呈現向上傾斜。同樣地,多年來呈現非周期性下降的股價會導致賣出後的圖表也呈現向下傾斜。這兩種情況的圖表都不能表示內部人士在進行內幕交易。

最有力的指標是在公司股價呈極度循環波動的情況下,「購買」圖表顯示正向信號,而「賣出」圖表顯示負向趨勢。這種情況強烈暗示內部人士可能根據內幕信息精確地計時進行交易,以獲得財務優勢。

歷史內部人交易

該表格顯示了由 Alan M Garber 進行的所有內幕交易的完整列表,這些交易已向美國證券交易委員會(SEC)披露。

呈報日期 交易日期 表格 證券代碼 證券 代碼 10b5-1 股份 剩餘股份 %
變化
每股
股價
交易
金額
剩餘
金額
2026-05-05 2026-05-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 472 7,344 6.87
2025-05-05 2025-05-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 398 6,872 6.15
2024-03-25 2024-03-21 4 EXEL EXELIXIS, INC.
Common Stock
S - Sale X -19,205 35,703 -34.98 24.01 -461,112 857,229
2024-03-25 2024-03-21 4 EXEL EXELIXIS, INC.
Common Stock
M - Exercise 23,491 54,908 74.77 19.57 459,719 1,074,550
2023-05-03 2023-05-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 584 6,474 9.92
2023-02-23 2023-02-21 4 EXEL EXELIXIS, INC.
Common Stock
S - Sale X -40,000 31,417 -56.01 17.49 -699,600 549,483
2023-02-23 2023-02-21 4 EXEL EXELIXIS, INC.
Common Stock
M - Exercise 40,000 71,417 127.32 6.30 252,000 449,927
2022-05-27 2022-05-26 4 EXEL EXELIXIS, INC.
Option (right to buy)
A - Award 42,422 42,422
2022-05-03 2022-05-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
A - Award 4,462 4,462
2022-03-03 2022-03-01 4 EXEL EXELIXIS, INC.
Option (right to buy)
M - Exercise -40,000 0 -100.00
2022-03-03 2022-03-01 4 EXEL EXELIXIS, INC.
Common Stock
S - Sale X -21,301 31,417 -40.41 21.00 -447,321 659,757
2022-03-03 2022-03-01 4 EXEL EXELIXIS, INC.
Common Stock
M - Exercise 40,000 52,718 314.51 3.13 125,200 165,007
2021-05-28 2021-05-27 4 EXEL EXELIXIS, INC.
Option (right to buy)
A - Award 33,549 33,549
2021-05-04 2021-05-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
A - Award 6,067 6,067
2021-03-17 2021-03-15 4 EXEL EXELIXIS, INC.
Option (right to buy)
M - Exercise -40,000 0 -100.00
2021-03-17 2021-03-15 4 EXEL EXELIXIS, INC.
Common Stock
S - Sale X -40,000 12,718 -75.88 23.60 -944,000 300,145
2021-03-17 2021-03-15 4 EXEL EXELIXIS, INC.
Common Stock
M - Exercise 40,000 52,718 314.51 3.38 135,200 178,187
2020-06-03 2020-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
A - Award 2,264 2,264
2020-06-03 2020-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 699 5,890 13.47
2020-05-22 2020-05-22 4 EXEL EXELIXIS, INC.
Common Stock
S - Sale X -36,111 12,718 -73.95 24.42 -881,831 310,574
2020-05-22 2020-05-21 4 EXEL EXELIXIS, INC.
Option (right to buy)
A - Award 30,750 30,750
2020-02-14 2020-02-14 4 EXEL EXELIXIS, INC.
Common Stock
S - Sale X -12,500 48,829 -20.38 21.02 -262,750 1,026,386
2020-01-09 2020-01-07 4 EXEL EXELIXIS, INC.
Option (right to buy)
M - Exercise -56,956 0 -100.00
2020-01-09 2020-01-07 4 EXEL EXELIXIS, INC.
Option (right to buy)
M - Exercise -30,000 0 -100.00
2020-01-09 2020-01-07 4 EXEL EXELIXIS, INC.
Common Stock
S - Sale X -86,956 61,329 -58.64 18.01 -1,566,078 1,104,535
2020-01-09 2020-01-07 4 EXEL EXELIXIS, INC.
Common Stock
M - Exercise 56,956 148,285 62.36 5.82 331,484 863,019
2020-01-09 2020-01-07 4 EXEL EXELIXIS, INC.
Common Stock
M - Exercise 30,000 91,329 48.92 4.58 137,400 418,287
2019-06-04 2019-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
A - Award 3,330 3,330
2019-06-04 2019-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 1,191 5,191 29.78
2019-05-24 2019-05-23 4 EXEL EXELIXIS, INC.
Option (right to buy)
A - Award 42,641 42,641
2019-04-03 2019-04-01 4 EXEL EXELIXIS, INC.
Option (right to buy)
S - Sale -15,000 0 -100.00
2019-04-03 2019-04-01 4 EXEL EXELIXIS, INC.
Option (right to buy)
S - Sale -15,000 0 -100.00
2019-04-03 2019-04-01 4 EXEL EXELIXIS, INC.
Common Stock
S - Sale X -15,000 61,329 -19.65 23.97 -359,550 1,470,056
2019-04-03 2019-04-01 4 EXEL EXELIXIS, INC.
Common Stock
M - Exercise 15,000 76,329 24.46 4.57 68,550 348,824
2019-04-03 2019-04-01 4 EXEL EXELIXIS, INC.
Common Stock
S - Sale X -15,000 61,329 -19.65 24.00 -360,000 1,471,896
2019-04-03 2019-04-01 4 EXEL EXELIXIS, INC.
Common Stock
M - Exercise 15,000 76,329 24.46 5.92 88,800 451,868
2019-01-09 2019-01-08 4 EXEL EXELIXIS, INC.
Option (right to buy)
M - Exercise -11,250 0 -100.00
2019-01-09 2019-01-08 4 EXEL EXELIXIS, INC.
Common Stock
S - Sale X -11,250 61,329 -15.50 23.00 -258,750 1,410,567
2019-01-09 2019-01-08 4 EXEL EXELIXIS, INC.
Common Stock
M - Exercise 11,250 72,579 18.34 4.16 46,800 301,929
2018-06-05 2018-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
A - Award 3,229 3,229
2018-06-05 2018-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 1,801 4,000 81.90
2018-05-24 2018-05-24 4 EXEL EXELIXIS, INC.
Option (right to buy)
A - Award 31,167 31,167
2018-04-18 2018-04-16 4 EXEL EXELIXIS, INC.
Option (right to buy)
M - Exercise -15,000 0 -100.00
2018-04-18 2018-04-16 4 EXEL EXELIXIS, INC.
Common Stock
S - Sale X -15,000 61,329 -19.65 20.25 -303,750 1,241,912
2018-04-18 2018-04-16 4 EXEL EXELIXIS, INC.
Common Stock
M - Exercise 15,000 76,329 24.46 11.66 174,900 889,996
2018-01-10 2018-01-09 4 EXEL EXELIXIS, INC.
Option (right to buy)
M - Exercise -11,500 0 -100.00
2018-01-10 2018-01-09 4 EXEL EXELIXIS, INC.
Common Stock
S - Sale X -11,500 61,329 -15.79 30.00 -345,000 1,839,870
2018-01-10 2018-01-09 4 EXEL EXELIXIS, INC.
Common Stock
M - Exercise 11,500 72,829 18.75 7.97 91,655 580,447
2018-01-10 2018-01-08 4 EXEL EXELIXIS, INC.
Option (right to buy)
M - Exercise -3,500 11,500 -23.33
2018-01-10 2018-01-08 4 EXEL EXELIXIS, INC.
Common Stock
S - Sale X -3,500 61,329 -5.40 31.29 -109,515 1,918,984
2018-01-10 2018-01-08 4 EXEL EXELIXIS, INC.
Common Stock
M - Exercise 3,500 64,829 5.71 7.97 27,895 516,687
2017-06-09 2017-06-08 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise 5,320 5,320
2017-06-09 2017-06-08 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 2,199 2,199
2017-05-26 2017-05-25 4 EXEL EXELIXIS, INC.
Option (right to buy)
A - Award 23,491 23,491
2016-12-09 2016-12-09 4 EXEL EXELIXIS, INC.
Option (right to buy)
M - Exercise -10,000 0 -100.00
2016-12-09 2016-12-09 4 EXEL EXELIXIS, INC.
Common Stock
S - Sale -7,832 61,329 -11.32 16.90 -132,361 1,036,460
2016-12-09 2016-12-09 4 EXEL EXELIXIS, INC.
Common Stock
M - Exercise 10,000 69,161 16.90 10.53 105,300 728,265
2016-05-26 2016-05-26 4 EXEL EXELIXIS, INC.
Option (right to buy)
A - Award 40,000 40,000
2016-01-05 2016-01-04 4 EXEL EXELIXIS, INC.
Common Stock
A - Award 10,550 59,161 21.70
2015-05-28 2015-05-28 4 EXEL EXELIXIS, INC.
Option (right to buy)
A - Award 40,000 40,000
2014-10-16 2014-10-14 4 EXEL EXELIXIS, INC.
Common Stock
A - Award 48,611 48,611
2014-05-30 2014-05-29 4 EXEL EXELIXIS, INC.
Option (right to buy)
A - Award 40,000 40,000
2013-12-09 2013-12-06 4 EXEL EXELIXIS, INC.
Option (right to buy)
A - Award 56,956 56,956
2013-05-24 2013-05-23 4 EXEL EXELIXIS, INC.
Option (right to buy)
A - Award 30,000 30,000
2012-05-25 2012-05-24 4 EXEL EXELIXIS INC
Option (right to buy)
A - Award 15,000 15,000
2008-05-05 2008-05-02 4 EXEL EXELIXIS INC
Option (right to buy)
A - Award 15,000 15,000
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券(例如股票期權)
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券(例如期權)
V
內部人士透過Form 4自願報告的一筆交易
J
其他(附有交易描述的腳註)